Dr. Nathaniel Hamilton Fleming, MD, MS

Dr. Fleming practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Fleming's NPI, 1316400245, was assigned on April 8, 2019. Dr. Fleming graduated from Stanford University School Of Medicine in 2019. Dr. Fleming holds California license A177834.

Dr. Fleming's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Fleming's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Fleming is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Fleming to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fleming practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Fleming's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Fleming is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Fleming is licensed in California.

CMS data shows 23 Medicare services from Dr. Fleming across 1 procedure code in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $2,840 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Fleming in 2024. The largest group is 75 to 84, with 23 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fleming's median patient age at 71, with 51% women.

In 2024, Dr. Fleming wrote 22 Medicare Part D claims for 12 patients. 91% of them were for generic drugs. CMS names the drug for 18 of them, across 1 drug with 11 or more claims each, at $816 in total drug cost. In 2022, CMS named 31 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Fleming for performance year 2024, reported as part of a group. Dr. Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fleming as offering telehealth.

Dmand AI links 15 papers to Dr. Fleming, published from 2013 to 2023. 2013 was the busiest year, with 2. The most frequent topics are Melanoma, Skin Neoplasms and Melanoma, Cutaneous Malignant. Dr. Fleming has published most often in JAMA Dermatol. Dr. Fleming's most frequent co-authors are Russell Scott Berman, MD, Anna C. Pavlick, DO and Susan Marie Swetter, MD.

Dr. Fleming graduated from Stanford University School Of Medicine in 2019.

Dr. Fleming is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.